BIOREGENX, INC. (BRGX)
About BIOREGENX, INC.
BIOREGENX INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.9M
- Net income
- -$1.5M
- Total assets
- $411.0K
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Bioregenx, Inc. (BRGX) Stock Price
- Reported a net loss of $1.5M in FY2025.
- Trading 50% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BIOREGENX, INC..
Write a review
News about BIOREGENX, INC.
News & sentiment via Polygon.io
Bioregenx, Inc.: frequently asked questions
Is Bioregenx, Inc. an American company?
Bioregenx, Inc. is a US-based company headquartered in Chattanooga, Tennessee, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Bioregenx, Inc. headquartered?
Bioregenx, Inc. is headquartered in Chattanooga, Tennessee, United States.
Is Bioregenx, Inc. publicly traded?
Yes — Bioregenx, Inc. is a publicly traded company. Its stock trades under the ticker symbol BRGX on the OTC.
What does Bioregenx, Inc. do?
Bioregenx, Inc. is an American Software company in the Technology & Electronics sector.
